Effect of opicapone in Parkinson's disease patients with 'early' motor fluctuations: Parkinson's disease questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience

被引：0
|
作者：
Rocha, J. [1 ]
Tolosa, E. [2 ]
Ferreira, J. [3 ]
Lees, A. [4 ]
Rascol, O. [5 ]
Poewe, W. [6 ]
Santos, A. [7 ]
Magalhaes, D. [1 ]
Soares-Da-Silva, P. [7 ]
机构：
[1] BIAL Portela & Ca SA, Global Parkinson Dis Dept, Coronado, Portugal
[2] Hosp Clin Univ Barcelona, Parkinson Dis & Movement Disorder Unit, Barcelona, Spain
[3] Inst Med Mol, Neurol Clin Res Unit, Lisbon, Portugal
[4] Natl Hosp Neurol & Neurosurg, London, England
[5] Univ Hosp Toulouse, Toulouse, France
[6] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
[7] BIAL Portela & Ca SA, R&D Dept, Coronado, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO3162
引用
收藏
页码：837 / 837
页数：1
相关论文
共 50 条
  • [21] A review of the validity and reliability of the Parkinson's Disease Questionnaire(PDQ-39)
    Stafkey-Mailey, DR
    Gwadry-Sridhar, F
    [J]. VALUE IN HEALTH, 2006, 9 (03) : A88 - A88
  • [22] Quality of life and parkinson's disease: Translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39)
    Donald M. Bushnell
    Mona L. Martin
    [J]. Quality of Life Research, 1999, 8 : 345 - 350
  • [23] Quality of life and parkinson's disease: Translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39)
    Bushnell, DM
    Martin, ML
    [J]. QUALITY OF LIFE RESEARCH, 1999, 8 (04) : 345 - 350
  • [24] Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39)
    Zoe Katsarou
    Sevasti Bostantjopoulou
    Viv Peto
    Anastasia Alevriadou
    Gregory Kiosseoglou
    [J]. Quality of Life Research, 2001, 10 : 159 - 163
  • [25] Efficacy and safety of opicapone in Parkinson's disease patients according to duration of motor fluctuations: post-hoc analysis of BIPARK-I and II
    Ebersbach, G.
    Rascol, O.
    Ferreira, J. J.
    Costa, R.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 659 - 660
  • [26] Efficacy of Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: a Post-Hoc Analysis from Double-Blind Combined BIPARK-I and II Data
    Hauser, Robert
    Ferreira, Joaquim J.
    Poewe, Werner
    Antonini, Angelo
    Rocha, Jose-Francisco
    Magalhaes, Diogo
    Soares-da-Silva, Patricio
    Klepitskaya, Olga
    Liang, Grace
    [J]. NEUROLOGY, 2020, 94 (15)
  • [27] Psychometric characteristics of the Parkinson's disease questionnaire (PDQ-39) -: Ecuadorian version
    Martínez-Martín, P
    Serrano-Dueñas, M
    Vaca-Baquero, V
    [J]. PARKINSONISM & RELATED DISORDERS, 2005, 11 (05) : 297 - 304
  • [28] Efficacy of opicapone in Parkinson's disease patients with motor fluctuations: A phase III, randomized, double-blind, placebo and active-controlled study - BIPARK I
    Ferreira, J.
    Lees, A.
    Santos, A.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2015, 30 : S85 - S86
  • [29] Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire
    Peto, V
    Jenkinson, C
    Fitzpatrick, R
    [J]. AGE AND AGEING, 2001, 30 (04) : 299 - 302
  • [30] Reliability and validity of the Parkinson's disease questionnaire (PDQ-39) -: Estonian version
    Krikmann, U.
    Taba, P.
    Asser, T.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 213 - 213
12345